Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Neohla Bio from Evergem, company number BE0801148536, closed financial year 2025 with a result of € -426,969 after tax. For that financial year Neohla Bio recorded a gross margin of € -54,742 and equity of € 347,377. Compared with financial year 2024, the result moved from € -177,875 to € -426,969. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.
€ 347,377
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -426,969
▼ 140 % more loss than in 2024
Profit after tax over the fiscal year.
€ 357,025
▲ 16% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -887,623.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 70,364
▲ 257% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -281,261 | € -57,076 | € -54,742 | ▲ € 2,334 |
| Profit after taxes | € -282,779 | € -177,875 | € -426,969 | ▼ € 249,093 |
| Equity | € -132,779 | € 324,345 | € 347,377 | ▲ 7% |
| Total debts | € 377,564 | € 19,688 | € 70,364 | ▲ 257% |
| Cash | € 222,293 | € 307,848 | € 357,025 | ▲ 16% |
| Retained profit | € -282,779 | € -460,655 | € -887,623 | ▼ € 426,969 |
| Bank debt | € 350,000 | € 0 | € 0 | |
| Balance sheet total | € 244,785 | € 344,034 | € 417,740 | ▲ 21% |
Key figures of Neohla Bio, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Neohla Bio?
What happened at Neohla Bio in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 426,969. Source: NBB ↗
- New establishment in Antwerpen. KBO
- Start of the company according to the CBE. KBO
- Groovy.bio became a director. NBB
In short
From € 282,779 loss in 2023 to € 426,969 loss in 2025.
Management
The stake of BIOQUBE FACTORY FUND I comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Neohla BioBehind Neohla Bio is Groovy.bio. The shares are held by BIOQUBE FACTORY FUND I (100%).
Directors
According to the 2025 annual accounts
since 2023
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Noorwegenstraat 4
9940 Evergem
Uitbreidingstraat 66 box 31
2600 Antwerpen
Active since 25 April 2023
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →LABORATORIUM M. NUYTINCK
€ 24.5 million revenue · 2025
LABO VOOR KLINISCHE BIOLOGIE
€ 3.6 million gross margin · 2025
POST VERBA VERBERA
€ 4.5 million revenue · 2025
ANABIOTEC
€ 9 million gross margin · 2025
Group Nuytinck
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0801.148.536
- VAT number
- BE 0801.148.536
- Registered office
- Noorwegenstraat 4, 9940 Evergem
- Names & denominations
- Neohla Bio
- Enterprise type
- Rechtspersoon
- Legal form
- Limited partnership
- Legal situation
- Normale toestand
- Start date
- 25 April 2023
- Peppol
- Active · Active since 12 Nov 2024
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied